The Molecular Basis of Vitamin D Receptor and β-Catenin Crossregulation (DOI:10.1016/j.molcel.2006.01.037);The molecular basis of vitamin D receptor and β-catenin crossregulation

Molecular Cell

Volumn 21, Issue 6, 2006, Pages 799-809

  Shah, Salimuddin ^a   Islam, Md Naimul ^a   Dakshanamurthy, Sivanesan ^a   Rizvi, Imran ^a   Rao, Mahadev ^a   Herrell, Roger ^a   Zinser, Glendon ^e   Valrance, Meggan ^e   Aranda, Ana ^b   Moras, Dino ^c   Norman, Anthony ^d   Welsh, JoEllen ^e   Byers, Stephen W ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CSIC   (Spain)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF NOTRE DAME   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,24 TRIHYDROXY 26,27 CYCLO 9,10 SECOCHOLESTA 5,7,10(19),22 TETRAENE 25 CARBOXYLIC ACID BUTYL ESTER; 25 DEHYDRO 1 ALPHA 25 DIHYDROXYVITAMIN D3 26, 23 LACTONE; BETA CATENIN; BUTYL 1,3,24 TRIHYDROXY 26,27 CYCLO 9,10(19),22 TETRAENE 25 CARBOXYLATE; CALCITRIOL; LYSINE; TEI 9647; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ACETYLATION; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; MOUSE; MUTATION; NONHUMAN; PROTEIN INTERACTION;

ANIMALIA;

EID: 33644850904     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.03.020     Document Type: Erratum

References (32)

1. C. Carlberg Molecular basis of the selective activity of vitamin D analogues J. Cell. Biochem. 88 2003 274 281
2. C. Carlberg Ligand-mediated conformational changes of the VDR are required for gene transactivation J. Steroid Biochem. Mol. Biol. 89-90 2004 227 232
3. H. Clevers Wnt breakers in colon cancer Cancer Cell 5 2004 5 6
4. D.L. Daniels, and W.I. Weis ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules Mol. Cell 10 2002 573 584
5. D. Dornan, H. Shimizu, N.D. Perkins, and T.R. Hupp DNA-dependent acetylation of p53 by the transcription coactivator p300 J. Biol. Chem. 278 2003 13431 13441
6. V. Easwaran, M. Pishvaian, Salimuddin, and S. Byers Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways Curr. Biol. 9 1999 1415 1418
7. M. Fu, C. Wang, X. Zhang, and R.G. Pestell Acetylation of nuclear receptors in cellular growth and apoptosis Biochem. Pharmacol. 68 2004 1199 1208
8. E. Giovannucci, and E.A. Platz Epidemiology of cancer risk: vitamin D and c D. Feldman J.W. Pike F.H. Glorieux Vitamin D 2005 Elsevier Academic Press Burlington, MA 1617 1634
9. D.A. Glass, P. Bialek, J.D. Ahn, M. Starbuck, M.S. Patel, H. Clevers, M.M. Taketo, F. Long, A.P. McMahon, R.A. Lang, and G. Karsenty Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation Dev. Cell 8 2005 751 764
10. T.D. Goddard, C.C. Huang, and T.E. Ferrin Software extensions to UCSF chimera for interactive visualization of large molecular assemblies Structure 13 2005 473 482
11. A. Hecht, K. Vleminckx, M.P. Stemmler, F. Van Roy, and R. Kemler The p300/CBP acetyltransferases function as transcriptional coactivators of beta-catenin in vertebrates EMBO J. 19 2000 1839 1850
12. J. Hulit, C. Wang, Z. Li, C. Albanese, M. Rao, D. Di Vizio, S. Shah, S.W. Byers, R. Mahmood, and L.H. Augenlicht Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice Mol. Cell. Biol. 24 2004 7598 7611
13. A.M. Jimenez-Lara, and A. Aranda Lysine 246 of the vitamin D receptor is crucial for ligand-dependent interaction with coactivators and transcriptional activity J. Biol. Chem. 274 1999 13503 13510
14. R.A. Laskowski, D.S. Moss, and J.M. Thornton Main-chain bond lengths and bond angles in protein structures J. Mol. Biol. 231 1993 1049 1067
15. P.J. Malloy, J.W. Pike, and D. Feldman The vitamin D receptor and the syndrome of hereditary 1,25-dihydroxyvitamin D-resistant rickets Endocr. Rev. 20 1999 156 188
16. P.J. Malloy, R. Xu, L. Peng, P.A. Clark, and D. Feldman A novel mutation in helix 12 of the vitamin D receptor impairs coactivator interaction and causes hereditary 1,25-dihydroxyvitamin D-resistant rickets without alopecia Mol. Endocrinol. 16 2002 2538 2546
17. M.T. Mizwicki, D. Keidel, C.M. Bula, J.E. Bishop, L.P. Zanello, J.M. Wurtz, D. Moras, and A.W. Norman Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1alpha,25(OH)2-vitamin D3 signaling Proc. Natl. Acad. Sci. USA 101 2004 12876 12881
18. R.T. Moon, A.D. Kohn, G.V. De Ferrari, and A. Kaykas WNT and beta-catenin signalling: diseases and therapies Nat. Rev. Genet. 5 2004 691 701
19. C.J. Narvaez, B.M. Byrne, S. Romu, M. Valrance, and J. Welsh Induction of apoptosis by 1,25-dihydroxyvitamin D3 in MCF-7 Vitamin D3-resistant variant can be sensitized by TPA J. Steroid Biochem. Mol. Biol. 84 2003 199 209
20. W.J. Nelson, and R. Nusse Convergence of Wnt, beta-catenin, and cadherin pathways Science 303 2004 1483 1487
21. H.G. Palmer, J.M. Gonzalez-Sancho, J. Espada, M.T. Berciano, I. Puig, J. Baulida, M. Quintanilla, A. Cano, A.G. de Herreros, M. Lafarga, and A. Munoz Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling J. Cell Biol. 154 2001 369 387
22. N. Rochel, J.M. Wurtz, A. Mitschler, B. Klaholz, and D. Moras The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand Mol. Cell 5 2000 173 179
23. N. Rochel, G. Tocchini-Valentini, P.F. Egea, K. Juntunen, J.M. Garnier, P. Vihko, and D. Moras Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor Eur. J. Biochem. 268 2001 971 979
24. A. Sali, and T.L. Blundell Comparative protein modelling by satisfaction of spatial restraints J. Mol. Biol. 234 1993 779 815
25. S. Shah, M.J. Pishvaian, V. Easwaran, P.H. Brown, and S.W. Byers The role of cadherin, beta-catenin, and AP-1 in retinoid-regulated carcinoma cell differentiation and proliferation J. Biol. Chem. 277 2002 25313 25322
26. S. Shah, A. Hecht, R. Pestell, and S.W. Byers Trans-repression of beta-catenin activity by nuclear receptors J. Biol. Chem. 278 2003 48137 48145
27. L.N. Song, R. Herrell, S. Byers, S. Shah, E.M. Wilson, and E.P. Gelmann Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription Mol. Cell. Biol. 23 2003 1674 1687
28. J.D. Thompson, D.G. Higgins, and T.J. Gibson CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice Nucleic Acids Res. 22 1994 4673 4680
29. G. Tocchini-Valentini, N. Rochel, J.M. Wurtz, and D. Moras Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification J. Med. Chem. 47 2004 1956 1961
30. N. Usami, Y. Sekido, O. Maeda, K. Yamamoto, J.D. Minna, Y. Hasegawa, H. Yoshioka, M. Imaizumi, Y. Ueda, M. Takahashi, and K. Shimokata Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion Oncogene 22 2003 7923 7930
31. J.L. Vanhooke, M.M. Benning, C.B. Bauer, J.W. Pike, and H.F. DeLuca Molecular structure of the rat vitamin D receptor ligand binding domain complexed with 2-carbon-substituted vitamin D3 hormone analogues and a LXXLL-containing coactivator peptide Biochemistry 43 2004 4101 4110
32. G.M. Zinser, K. McEleney, and J. Welsh Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice Mol. Cell. Endocrinol. 200 2003 67 80